secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dermata Therapeutics, Inc. (DRMA)
CIK:        0001853816
Form:       8-K
Filed at:   2024-05-15T23:59:59+00:00
Accession:  0001654954-24-006312
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Dermata gets 180-day Nasdaq extension; files 1:15 reverse stock split to regain compliance
--------------------------------------------------------------------------------

- Received Nasdaq extension until November 11, 2024 to meet $1.00 minimum bid price.
- Reverse stock split (1:15) effective May 16, 2024 to increase per-share price.
- Nasdaq warned delisting if compliance not regained by the November deadline.
- Company cautions no assurance of regaining compliance or meeting other listing rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1853816/000165495424006312/0001654954-24-006312-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1853816/000165495424006312/drma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-006312

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer